Different approaches for improving skin accumulation of topical corticosteroids

International Journal of Pharmaceutics

Volumn 380, Issue 1-2, 2009, Pages 155-160

  Şenyiǧit, Taner ^a,b   Padula, Cristina ^b   Özer, Özgen ^a   Santi, Patrizia ^b  

^a EGE UNIVERSITY   (Turkey)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Chemical enhancers; Gel; Iontophoresis; Skin retention; Topical glucocorticoids; Vehicle effects

Indexed keywords

CHITOSAN; CLOBETASOL PROPIONATE; CORTICOSTEROID; DEOXYCHOLATE SODIUM; DIETHYLENE GLYCOL MONOETHYL ETHER; LIMONENE; MOMETASONE FUROATE; NEROLIDOL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG FORMULATION; DRUG STRUCTURE; DRUG TARGETING; ELECTRIC CURRENT; EPIDERMIS; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; SKIN; STRATUM CORNEUM; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ANIMALS; ANTI-INFLAMMATORY AGENTS; CHEMISTRY, PHARMACEUTICAL; CLOBETASOL; CYCLOHEXENES; EAR, EXTERNAL; ETHYLENE GLYCOLS; GELS; IONTOPHORESIS; PERMEABILITY; PHARMACEUTICAL VEHICLES; PREGNADIENEDIOLS; SESQUITERPENES; SKIN; SKIN ABSORPTION; SWINE; TERPENES;

EID: 69549107490     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.07.018     Document Type: Article

References (39)

1. Aqil M., Ahad A., Sultana Y., and Ali A. Status of terpenes as skin penetration enhancers. Drug Discov. Today 12 (2007) 1061-1067
2. Asbill C.S., and Michniak B.B. Percutaneous penetration enhancers: local versus transdermal activity. PSTT 3 (2000) 36-41
3. Banga A.K., Bose S., and Ghosh T.K. Iontophoresis and electroporation: comparisons and contrasts. Int. J. Pharm. 179 (1999) 1-19
4. Bhatia K.S., Gao S., and Singh J. Effect of penetration enhancers and iontophoresis on the FT-IR spectroscopy and LHRH permeability. J. Control. Release 47 (1997) 81-89
5. Bos J.D. Non-steroidal topical immunomodulators provide skin-selective, self limiting treatment in atopic dermatitis. Eur. J. Dermatol. 13 (2003) 455-461
6. Brazzini B., and Pimpinelli N. New and established topical corticosteroids in dermatology. Am. J. Clin. Dermatol. 3 (2002) 47-58
7. Choi E.H., Lee S.H., Ahn S.K., and Hwang S.M. The pretreatment effect of chemical skin penetration enhancers in transdermal drug delivery using iontophoresis. Skin Pharmacol. Appl. Skin Physiol. 12 (1999) 326-335
8. Cornwell P.A., and Barry B.W. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorourocil. J. Pharm. Pharmacol. 46 (1994) 261-269
9. Crim C., Pierre L.N., and Daley-Yates P.T. A review of pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate. Clin. Ther. 23 (2001) 1339-1354
10. Delgado-Charro M.B., and Guy R.H. Characterization of convective solvent flow during iontophoresis. Pharm. Res. 11 (1994) 929-935
11. El-Kattan A.F., Asbill C.S., Kim N., and Michniak B.B. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int. J. Pharm. 215 (2001) 229-240
12. El-Kattan A.F., Asbill C.S., and Michniak B.B. The effects of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int. J. Pharm. 198 (2000) 179-189
13. Fang J.Y., Fang C.L., Sung K.C., and Chen H.Y. Effect of low frequency ultrasound on the in vitro percutaneous absorption of clobetasol 17-propionate. Int. J. Pharm. 191 (1999) 33-42
14. ® CG on the skin accumulation and transdermal permeation of ultraviolet absorbers. Eur. J. Pharm. Biopharm. 53 (2002) 23-27
15. Green P., Flanagan M., Shroot B., and Guy R.H. Iontophoretic drug delivery. In: Walters K.A., and Hadgraft J. (Eds). Pharmaceutical Skin Penetration Enhancement (1993), Marcel Dekker, New York 320-322
16. Guy R.H., Kalia Y.N., Delgado-Charro M.B., Merino V., Lopez A., and Marra A. Iontophoresis: electrorepulsion and electroosmosis. J. Control. Release 64 (2000) 129-132
17. Hejazi R., and Amiji M. Chitosan based gastrointestinal delivery systems. J. Control. Release 89 (2003) 151-165
18. Kaplun-Frischoff Y., and Touitou E. Testesterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids. J. Pharm. Sci. 86 (1997) 1394-1399
19. Kikwai L., Kanikkannan N., Babu R.J., and Singh M. Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro. J. Control. Release 83 (2002) 307-311
20. Marro D., Guy R.H., and Delgado-Charro M.B. Characterization of the iontophoretic permselectivity properties of human and pig skin. J. Control. Release 70 (2001) 213-217
21. Mitragotri S. Synergistic effect of enhancers for transdermal drug delivery. Pharm. Res. 17 (2000) 1354-1359
22. Moffat A.C. Clarke's Isolation and Identification of Drugs. 2nd Ed. (1986), The Pharmaceutical Press, London p. 476
23. Moster K., Kriwet K., Naik A., Kalia Y.N., and Guy R.H. Passive skin penetration enhancement and its quantification in vitro. Eur. J. Pharm. Biopharm. 52 (2001) 103-112
24. Mura P., Faucci M.T., Bramanti G., and Corti P. Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur. J. Pharm. Sci. 9 (2000) 365-372
25. Oh S.Y., Jeong S.Y., Park T.G., and Lee J.H. Enhanced transdermal delivery of azt (zidovudine) using iontophoresis and penetration enhancer. J. Control. Release 51 (1998) 161-168
26. Padula C., Sartori F., Marra F., and Santi P. The influence of iontophoresis on acyclovir transport and accumulation in rabbit ear skin. Pharm. Res. 22 (2005) 1519-1524
27. Pikal M.J. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug. Deliv. Rev. 9 (1992) 201-237
28. Prakash A., and Benfield P. Topical mometasone: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. Drugs 55 (1998) 145-163
29. Ritschel W.A., Panchagnula R., Stemmer K., and Ashraf M. Development of an intracutaneous depot for drugs. Binding, drug accumulation and retention studies, and mechanism of depot. Skin Pharmacol. 4 (1991) 235-245
30. Schackert C., Korting H.C., and Schafer-Korting M. Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo characterisation of drugs with an increased benefit-risk ratio. BioDrugs 13 (2000) 267-277
31. Sekkat N., Kalia Y.N., and Guy R.H. Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo. J. Pharm. Sci. 91 (2002) 2376-2381
32. Sinha V.R., and Pal Kaur M. Permeation enhancers for transdermal drug delivery. Drug Dev. Ind. Pharm. 26 (2000) 1131-1140
33. Smith H.D., Becket G., and Meths S. Effect of permeation enhancer pretreatment on the iontophoresis of luteinizing hormone releasing hormone (LHRH) through human epidermal membrane (HEM). J. Pharm. Sci. 91 (2002) 1296-1307
34. Şenyiǧit T., and Özer O. Evaluation of sodium-deoxycholate gels containing betamethasone-17-valerate. 35th Controlled Release Society Annual Meeting & Exposition. New York, USA (2008)
35. Thong H.Y., Zhai H., and Maibach H.I. Percutaneous penetration enhancers: an overview. Skin Pharmacol. Physiol. 20 (2007) 272-282
36. Valenta C., Nowack E., and Bernkop-Schnürch A. Deoxycholate-hydrogels: novel drug carrier systems for topical use. Int. J. Pharm. 185 (1999) 103-111
37. Volpato N.M., Nicoli S., Laureri C., Colombo P., and Santi P. In vitro acyclovir distribution in human skin layers after transdermal iontophoresis. J. Control. Release 50 (1998) 291-296
38. Wiedersberg S., Leopold C.S., and Guy R.H. Bioavailability and bioequivalence of topical glucocorticoids. Eur. J. Pharm. Biopharm. 68 (2008) 453-466
39. Williams A.C., and Barry B.W. Penetration enhancers. Adv. Drug. Deliv. Rev. 56 (2004) 603-618